Background. Drug overdose is an important, yet an inadequately understood, public health problem. Global attention to unintentional drug overdose has been limited by comparison with the scope of the problem. There has been a substantial increase in drug overdose incidence and prevalence in several countries worldwide over the past decade, contributing to both increased costs and mortality.
Objectives. The aim of this study was to systematically synthesize the peer-reviewed literature to document the global epidemiological profile of unintentional drug overdoses and the prevalence, time trends, mortality rates, and correlates of drug overdoses. We searched different combinations of Medical Subject Headings (MeSH) terms in PubMed for articles published from 1980 until July 2013, and we organized these results in tabular spreadsheets and compared them. We restricted the search to English-language articles that deal with unintentional overdose, focusing on 1 or more of the following key constructs: prevalence, time trends, mortality rates, and correlates. The term "overdose" as a MeSH major topic yielded 1076 publications. In addition, we searched the following combinations of nonmajor MeSH terms: "street drugs" and "overdose" yielded 180, "death" and "overdose" yielded 114, and "poisoning" and "drug users" yielded 17. There was some overlap among the searches. Based on the search and inclusion and exclusion criteria, we selected a total of 169 relevant articles for this article based on a close review of abstracts.
Results. We found wide variability in lifetime prevalence of experiencing a nonfatal overdose or witnessing an overdose, and in mortality rates attributable to overdose. Lifetime prevalence of witnessed overdose among drug users (n = 17 samples) ranged from 50% to 96%, with a mean of 73.3%, a median of 70%, and a standard deviation of 14.1%. Lifetime prevalence of drug users personally experiencing a nonfatal overdose (n = 27 samples), ranged from 16.6% to 68.0% with a mean of 45.4%, a median of 47%, and a standard deviation of 14.4%. Population-based crude overdose mortality rates (n = 28 samples) ranged from 0.04 to 46.6 per 100 000 person-years. This range is likely attributable to the diversity in regions, time periods, and samples. Most studies on longitudinal trends of overdose death rates or overdose-related hospitalization rates showed increases in overdose death rates and in overdose-related hospitalization rates across time, which have led to peaks in these rates at the present time. An overall trend of increasing deaths from prescription opioid use and decreasing deaths from illicit drug use in the past several years has been noted across most of the literature. With the increase in prescription opioid overdose deaths, drug overdose is not just an urban problem: rural areas have seen an important increase in overdose deaths. Lastly, cocaine, prescription opioids, and heroin are the drugs most commonly associated with unintentional drug overdoses worldwide and the demographic and psychiatric correlates associated with unintentional drug overdoses are similar globally.
Conclusions. There isa need to invest in research to understand the distinct determinants of prescription drug overdose worldwide. Several other countries need to collect in a systematic and continuous fashion such data on sales of prescription opioids and other prescription drugs, nonmedical use of prescription drugs, and hospitalization secondary to overdoses on prescription drugs. The sparse evidence on the environmental determinants of overdose suggests a need for research that will inform the types of environmental interventions we can use to prevent drug overdose. Methodological issues for future studies include enhancing data collection methods on unintentional fatal and nonfatal overdoses, and collecting more detailed information on drug use history, source of drug use (for prescription drugs), and demographic and psychiatric history characteristics of the individual who overdosed. (Am J Public Health. 2015;105:e29-e49. doi:10.2105/AJPH.2015.302843)
PLAIN-LANGUAGE SUMMARY:
Drug overdose is an important, yet inadequately understood, public health problem. The aim of this study was to systematically summarize the peer-reviewed literature to document the global epidemiological profile of unintentional drug overdoses, and the prevalence, time trends, mortality rates, and correlates of drug overdoses from 1980 until 2013. We found wide variability in prevalence mortality rates attributable to overdose. Most studies on longitudinal trends of overdose deaths or overdose-related hospitalizations showed increases across time. An overall trend of increasing deaths from prescription opioid use and decreasing deaths from illicit drug use in the past several years has been noted across most of the literature. With the increase in prescription opioid overdose deaths, drug overdose is not just an urban problem: rural areas have seen an important increase in overdose deaths. Lastly, cocaine, prescription opioids, and heroin are the drugs most commonly associated with unintentional drug overdoses worldwide and the demographic and psychiatric correlates associated with unintentional drug overdoses are similar globally. Future studies need to collect more detailed information on drug use history, source of drug use (for prescription drugs), and demographic and psychiatric history characteristics of the individual who overdosed.
Worldwide attention to unintentional drug overdose has been limited by comparison with the scope of the problem. 1 Until recently, drug overdoses were seen as a substance abuse or law enforcement issue and not as a public health problem.
1 However, partly because of the increasing involvement of legal prescription drugs such as prescription opioids in drug overdoses, public health professionals have become more interested in the topic and in diminishing the societal burden posed by unintentional overdoses. 1 Although drug overdose deaths attract much public attention, 1,6---8 there are substantial consequences of nonfatal overdose, including cardiac and muscular problems, cognitive impairment, renal failure, hearing loss, and injuries sustained during overdose. 9 Drug overdose can be defined as happening when someone . . . collapses, has blue skin, has convulsions, has difficulty breathing, loses consciousness, cannot be woken up, has a heart attack or dies while using drugs. 12(p704) This definition has been used widely across the literature. 13---16 Unintentional drug overdoses are unique among causes of morbidity and mortality in 2 respects. First, unintentional overdose deaths are rarely instantaneous and drug users rarely overdose alone. As such, for the most part, overdose deaths are avoidable deaths. For example, those who witness an overdose episode can call for help and apply first aid measures. 16 Opioid overdoses are preventable through the administration of naloxone, which can reverse the effect of opioids and can revive the individual. 16---18 Second, drug overdoses are inevitably and inextricably linked to the surrounding environment, particularly in the centrality of drug availability as a necessary (but insufficient) determinant of overdose.
19---23
Considering these observations that overdose is preventable and linked to surrounding environment, drug overdoses should be of concern to public health, both from the point of view of understanding their determinants and from the point of view of encouraging interventions to mitigate their consequences. A systematic review of the drug overdose literature can help clarify what we know about unintentional drug overdoses and areas in which we have gaps in scholarship. Although reviews have been written about overdoses caused by particular types of drugs (e.g., prescription opioids, heroin, methadone), 24---27 in certain places (e.g., Utah), 28 on suicidal versus accidental overdose, 29 or on overdoses among recently released prisoners, 30 we are not aware of any global review of unintentional drug overdoses with the goal of synthesizing the prevalence, time trends, mortality rates, and correlates of drug overdose worldwide.
METHODS
The potential scope of literature that may be considered of interest to the topic is vast. We conducted a systematic review of publications available in the US National Library of Medicine's PubMed electronic database 31 in July 2013 by using different combinations of Medical Subject Headings (MeSH) search terms. We restricted the search to English-language articles published between 1980 and July 2013 that deal with unintentional overdose, focusing on 1 or more of the following key constructs: prevalence, time trends, mortality rates, and correlates. The term "overdose" as a MeSH Major Topic yielded 1076 publications. In addition, we searched the following combinations of nonmajor MeSH terms: "street drugs" and "overdose" yielded 180, "death" and "overdose" yielded 114, and "poisoning" and "drug users" yielded 17. There was some overlap among the searches. We did not use "unintentional" as a search term so as not to leave out studies that dealt with both intentional and accidental overdoses. There were no limitations in this original search on type of sample, or location or geography, but we excluded studies dealing with children, because, although this group is important, we aimed to focus only on studies that reported on unintentional drug overdoses among adults. We included commentaries because of their potential to shed light on potential interventions or trends. In addition, we reviewed reference lists of chosen articles to select additional studies or commentaries. With these search and inclusion and exclusion criteria, we selected a total of 169 relevant articles for this study through a close review of abstracts ( Figure 1 ). We were interested in articles that reported 1. population-based prevalence measures (46 articles; reported in Table 1 ), 2. studies that reported percentage of changes over time in trends of overdose (34 articles; Table 2 ), 3. mortality rates (53 articles; Table 3 ), and 4. correlates of overdose (summarized in the Results section, but not included in tables because of the lack of common quantitative measures to record these topics). Table 1 shows prevalence of overdose found in relevant articles, organized by type of drug, sample, and type of prevalence (witnessed vs experienced, fatal vs nonfatal, and time point). Lifetime prevalence of witnessed overdose among drug users (n = 17 samples from 18 articles) ranged from 50% to 96%, prescription opioids, cocaine), the lifetime prevalence of witnessing an overdose did not differ greatly between studies conducted in different settings and countries.
RESULTS
Two studies reported lifetime prevalence of witnessing a fatal overdose specifically: 1 found that 4 of 24 drug users attending a general medical practice in inner-city Dublin, Ireland, in 1998 to 1999 had witnessed a fatal overdose 40 ; the other reported a 15% prevalence among 763 injection drug users from 16 different cities of the Russian Federation. 59 Two studies reported An overall trend of increasing deaths from prescription opioid use and decreasing deaths from illicit drug use in the past several years has been noted across most of the literature. 80---82,89,90,96,97,99, 100 With the exception of Australia, which experienced a 60% decrease in opioid deaths between 1990 and 2001, 91 most studies in Table 2 reported increased rates of deaths from opioids. Participants were users who had been injecting for at least 1 year, had injected heroin within the past 2 months, and were aged ‡ 18 years.
c Snapshot of fourth wave (n = 568); recruited through street-based outreach, advertisements, and word of mouth; inclusion criteria were aged ‡ 18 years, having daily contact with drug users, and willingness to conduct HIV prevention outreach.
d A longitudinal naturalistic multisite study; participants included 2966 patients with ‡ 1 substance abuse disorders.
e Participants were recruited for a health service research study on drug users if they (1) were aged 18-70 years; (2) had injected heroin or cocaine during the preceding 30 days, or noninjection heroin or cocaine use at least weekly for the past 6 months; (3) had < 30 of the last 90 days spent in institutional settings including prisons and residential drug treatments or hospitalization; (4) spoke English; (5) denied intent to harm self or others; and (6) had absence of psychosis.
f
The cohort consisted of entrants to treatment of heroin dependence in opioid maintenance, detoxification, and residential rehabilitation; in addition, a group of heroin users not currently in treatment were recruited from needle and syringe programs in the regional health areas from which treatment entrants were recruited. IDUs, most of whom were homeless or in temporary housing, aged ‡ 18 y; participants were recruited via street outreach, distribution of advertising leaflets, and 1-on-1 recruitment within the HRC. k IDUs aged < 30 years, recruited by peer outreach workers with study invitation cards and flyers, contacts with youth-friendly neighborhood groups and community providers, and word of mouth; had to have self-reported use of injection drugs in the past 30 days.
l Outreach and word of mouth using targeted sampling methods; eligibility determined by physical evidence of recent injection drug use ("tracks" or multiple venipuncture sites) or participation in previous cross-sections of data collection (final n = 82 who had experienced an overdose and wanted to participate, out of original 552). 
Mortality Rates
Relevant studies that reported either population-based mortality rates attributable to fatal drug overdose, or all-cause and cause-specific death rates among drug users, are presented in Table  3 , organized by type of drug, location and time period, and sample. Rates are crude and overdose-related, unless otherwise noted in the table. Rates are reported as number of deaths per 100 000 person-years; we converted original rates from articles that were presented on a different scale accordingly. Mortality rates differed widely depending on the setting and on the source population (i.e., any substance users, injection drug users only, recently released prisoners).
Population-based crude overdose mortality rates (n = 30 samples from 22 articles) ranged from 0.04 to 46.6 per 100 000 person-years. g "Presentations highlighting six recommended prescribing practices were developed and presented to health care workers. Participants were encouraged to utilize the state prescription database and to complete a series of surveys assessing confidence and behavior changes at 0, 1, and 6 months post-presentation. Continuing medical education credits incentivized participation." l Australian Treatment Outcome Study cohort consists of entrants to treatment of heroin dependence in opioid maintenance, detoxification, and residential rehabilitation; in addition, a group of heroin users not currently in treatment were recruited from needle and syringe programs in the regional health areas from which treatment entrants were recruited. 
119, 120
Correlates Type of drug. Substances most commonly associated with overdose include cocaine, nonopioid analgesics (i.e., nonsteroidal antiinflammatory drugs), and opioidsa class of drug that includes heroin, as well as prescription opioids such as morphine, methadone, codeine, and oxycodone. Some findings on how class of drug used affects overdose outcome are highlighted here.
Cocaine was one of the major drivers of overdose in the 1990s and early 2000s, especially in urban areas such as New York City. 22, 23 In a study of witnessed overdoses in New York City in the early 2000s, powdered cocaine use predicted fatality among respondents' reported last witnessed overdose. 17 However, a shift toward opioids has occurred worldwide throughout the past several years.
135
In a study of fatal overdoses in Connecticut, 77% of accidental overdose deaths from 1997 to 2007 involved opioids. 90 Opioid deaths were also more likely to involve alcohol and benzodiazepines. 2, 85, 90 Several articles focused on fentanyl, an opioid receptor agonist that is used as a filler for street heroin (or laced into heroin and cocaine) and has been more frequently prescribed in recent years. 136, 137 Fentanyl is estimated to be 80 times more potent than morphine, so a small change in dosage may be fatal.
Compounding this issue, many narcotic drug screens do not routinely screen for fentanyl. 138 Only 1 of the studies that included prescription medications 69 differentiated between those who experienced overdoses secondary to nonmedical use (i.e., using in larger amounts than prescribed or not prescribed for them) and had been prescribed these drugs versus those who experienced overdoses but had never been prescribed these drugs. Of the 596 respondents included in this study, 72.8% had already been prescribed in their lifetime prescription opioids, 45.5% had already been prescribed prescription tranquilizers, and 45.1% had already been prescribed prescription stimulants. None of the mortality articles included in our review had information on whether those who died because of overdoses secondary to prescription drug use had been using these drugs for therapeutic purposes.
Whether drugs are taken in pure form on their own or combination form (including mixed with alcohol) is important. 16, 77 "Polydrug" use is associated with a much higher risk of death from overdose; a study of opioid In addition, the setting and circumstances of a drug overdose can tell us a lot about potential outcomes. In a study of fatal overdose in New York City in 1996, deaths were more likely to occur in neighborhoods in the top decile of income inequality than in more equitable neighborhoods. 145 This relationship was partially explained by the level of disorder in the environment and the quality of the built environment. When compared with nonoverdose but unintentional deaths, prescription opioid overdose deaths from another study in New York City were more likely to occur in lowerincome and "fragmented" neighborhoods, but when compared with heroin fatalities, they were more likely to occur in higherincome and less-fragmented neighborhoods.
146 One explanation for this is that higher-income neighborhoods offer a larger supply of prescription opioids through pharmacies and physicians that is not present in more disadvantaged, primarily minority neighborhoods. A study in 10 Spanish cities from 1996 to 2003 found that male overdose deaths were more common in cities with high levels of socioeconomic inequality.
147
The physical settings in which users inject also matter. A Vancouver study estimated that users who injected in public places (vs those who injected in private settings) were 4.7 times more likely to experience a nonfatal overdose. 19 A study by Bohnert et al.
on policing and risk of overdose in New York City found that fatal overdoses were more likely to occur in secluded public places, such as abandoned buildings.
20
This is likely attributable to the fact that it is more difficult to find help when someone overdoses, and may be a result of fear of heavy policing in urban areas. Another study that investigated risks of heroin overdose noted injection in an "unusual place" (defined by each individual according to his or her injecting habits) as a risk factor for overdoses. 21 One explanation presented for this phenomenon is that tolerance is based on Pavlovian conditioning of cues, and when a user of typically high tolerance injects in an unusual circumstance, they lack the cues that they usually associate with a drug's effect, causing their tolerance to fail.
148
Characteristics of the user. Lastly, characteristics of the drug user are important to consider as correlates for drug overdose. One characteristic of note is gender. Men are more likely to self-report nonmedical use of prescription drugs, yet more women are more often prescribed drugs prone to abuse. 149, 150 This might be because of the fact that many common forms of pain such as osteoarthritis, fibromyalgia, lower-back pain, and shoulder pain are more prevalent among women, and women also report higher intensity of pain from these conditions. 151, 152 The US Centers 108 An investigation of fatal accidental drug overdose in New York City between 1990 and 1998 found that overdose deaths were consistently higher among non-Hispanic Blacks and Hispanics compared with non-Hispanic Whites. In addition, cocaine was more common among non-Hispanic Black decedents, whereas opioids and alcohol were more common among Hispanic and non-Hispanic White decedents. 22 On the other hand, rates of prescription opioid deaths are higher among non-Hispanic Whites than among respondents of other races/ethnicities.
153
Other factors associated with increased risk of nonfatal overdose found in the literature review included belonging to a lower income group while growing up, not graduating high school, being a smoker, having ever received care at a psychiatric facility, ever witnessing a family member overdose, being prescribed tranquilizers, having cocaine dependence, and injecting in the past 90 days. 28, 36, 69, 154 Certain subgroups of the population are especially prone to overdose risk, including homeless individuals, HIV-positive individuals, and recently released prisoners. 65, 120, 155, 156 Individuals who have recently attended substance abuse treatment or been released from incarceration are at increased risk of overdose, often because they have lost tolerance for their usual doses. 26, 157 Overdose is also significantly associated with psychiatric disorders, suicidal ideation, and attempted suicide. 67, 158 Lastly, duration of drug use and reports of previous overdose episodes are associated with overdose.
159, 160

DISCUSSION
We systematically synthesized the peer-reviewed literature to document the global epidemiological profile of unintentional drug overdoses, and the prevalence, time trends, mortality rates, and correlates of drug overdoses. We found, first, wide variability in the lifetime prevalence of experiencing a nonfatal overdose and in mortality rates attributable to overdoses, depending on the study setting. Second, the majority of studies on longitudinal trends of overdose death rates or overdose-related hospitalization rates showed increases in overdose death rates and in overdose-related hospitalization rates across time, which have led to peaks in these rates now. In particular, an overall trend of increasing deaths from prescription opioid use and decreasing deaths from illicit drug use in the past several years has been noted across most of the literature. 80---82,89,90,96,97,99,100 Third, with the increase in prescription opioid overdose deaths, drug overdose is no longer just an urban problem: rural areas have seen an important increase in overdose deaths. Fourth, cocaine, prescription opioids, and heroin are the drugs most commonly associated with unintentional drug overdoses worldwide and the demographic and psychiatric correlates associated with unintentional drug overdoses are similar worldwide. However, more studies examining these correlates are needed from non---English-speaking countries.
Drug overdose is an important, yet inadequately understood, public health problem. A review of existing studies points to several key methodological issues that future studies need to address and limitations in extant studies. Methodological issues include enhancing data collection methods on unintentional fatal and nonfatal overdoses, and collecting more detailed information on drug use history, source of drug use (for prescription drugs), and demographic and psychiatric history characteristics of the individual who overdosed. For example, future studies could employ consistency check strategies to compare medical examiner information on fatal overdoses with available medical records and information from the deceased individuals' family members.
Future data collection efforts could also include more detailed questions when interviewing individuals who report nonfatal overdoses, and check consistency of such information with hospital discharge data and information from family or other third parties (e.g., friends who witnessed the overdose episode). The field still also lacks studies in rural areas as well as longitudinal studies of population-based drug users (i.e., non---treatment samples) in multiple urban and rural areas that would provide us with comparable prevalence estimates across different contexts.
In addition, several of the selected studies did not disclose how they defined nonfatal overdoses to study respondents, 33, 34, 37 simply mentioning that they asked them if they had ever experienced or witnessed an overdose, which could be somewhat misleading and biased. On the other hand, it should be noted that, among the studies that provided information on the definition of nonfatal overdoses, the definition of nonfatal overdoses was overall extremely consistent and standardized across the reviewed studies, similar to the definition we present in the introduction of this review.
12, 14---17,36,39,40
The marked increase in prescription opioid overdoses described in the studies reviewed is likely attributable to a rapid increase in sales of prescription opioids during the past decade; the quantity of prescription opioids sold to pharmacies, hospitals, and doctors' offices in the United States was 4 times larger in 2010 than in 1999. 8 The increase in overdoses caused by prescription opioid use in the United States parallels the increase in the availability of prescription opioids since the early to mid-1990s in the United States. 90 As described in one of Nora Volkow's recent presentations to the US Senate:
The number of prescriptions for opioids (like hydrocodone and oxycodone products) have escalated from around 76 million in 1991 to nearly 207 million in 2013, with the United States their biggest consumer globally, accounting for almost 100 percent of the world total for hydrocodone (i.e., Vicodin) and 81 percent for oxycodone (i.e., Percocet). 161(p3) There is a need to invest in research to understand the distinct determinants of this type of overdose worldwide. Several other countries need to collect in a systematic and continuous fashion such data on sales of prescription opioids and other prescription drugs, nonmedical use of prescription drugs, and hospitalization secondary to overdoses on prescription drugs. Moreover, there is the need for future studies to further investigate whether those who overdose while using prescription medication had been prescribed these drugs recently or in the past because only 1 of the reviewed studies included this information. 69 Finally, the sparse evidence on the environmental determinants of overdose suggest a need for research that will inform the types of environmental interventions we can use to prevent drug overdose. A combination of studies on individuals who overdose and the settings where overdoses occur will help us better tailor interventions to the types of strategies that are most likely to have a major impact on this epidemic.
Limitations of the reviewed studies are also noted. First, most studies did not collect information on the sources of drug used, which can provide insights into the ways individuals learn about and acquire drugs, and can thus inform prevention opportunities. Drugs can be acquired from family, friends, and drug dealers, but they can also be prescribed for legitimate medical reasons (in the case of prescription drugs). More studies that investigate prescribing patterns, such as the article by Logan et al. on potentially inappropriate prescriptions given in the emergency department, 162 are needed. Moreover, only about a third of the mortality rate studies, half of trends studies, and one sixth of the prevalence studies stratify results by specific types of prescription drugs. Second, it is already well established that there might be an underreporting of intentional overdoses, because when substance users are asked whether their overdose was or was not intentional, most report it as unintentional. 29, 163, 164 In our review, we focused on unintentional overdoses, but there is the possibility that some of these overdoses were truly intentional. Third, because substance users who experience an overdose are usually polydrug users, it is very difficult to distinguish which and how many drugs were used before an overdose episode. 165---168 Because of the high prevalence of multiple drugs being present in overdoses, 11, 139 it is hard to tease out the effect of one drug over another. Overall, there is a mix of how well studies differentiate, but many aim to show an overall measure of burden of this issue, not truly trying to make a causal association with any 1 type of drug. Fourth, studies have shown that forensic toxicology laboratories are limited in the number of drugs for which they can screen and that drug levels can change postmortem. 165---168 Further complicating this issue is the fact that data collected by medical examiners and coroners are usually inadequate, incomplete, and inconsistent with regard to polydrug use, estimated drug dosage (when, for instance, the individual had a legitimate prescription for at least 1 of the drugs involved in the fatal overdose episode-e.g., a legitimate opioid prescription), and patient characteristics. 169 Fifth, if we are to identify potential avenues to prevent drug overdose, more concerted investment needs to be made to understand the environmental drivers of overdose risk, and the individual and interpersonal mechanisms whereby environmental characteristics can increase the risk for overdose. This is particularly important for overdose risk in rural areas, as the bulk of the literature on environmental determinants of overdose has focused on urban areas. This also has important implications for prevention and intervention strategies that need to focus on harm reduction strategies such as the availability of safe injection facilities or mobile safe injection facilities where individuals can inject preobtained drugs under the supervision of a medical doctor, such as facilities that exist in Canada and in some European countries, 19 while also offering them treatment for their drug-using behavior. j S. S. Martins was a consultant for Purdue Pharma until December 2014 to collaborate on a manuscript on secondary analyses of National Epidemiologic Survey on Alcohol and Related Conditions data on prescription opioid dependence.
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